Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life-Reference-Cited by-同舟云学术

Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life

Published:2017-03 Issue:3 Volume:107 Page:788-795.e2
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Pinola Pekka,Puukka Katri,Piltonen Terhi T.,Puurunen Johanna,Vanky Eszter,Sundström-Poromaa Inger,Stener-Victorin Elisabet,Lindén Hirschberg Angelica,Ravn Pernille,Skovsager Andersen Marianne,Glintborg Dorte,Mellembakken Jan Roar,Ruokonen Aimo,Tapanainen Juha S.,Morin-Papunen Laure C.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference41 articles.

1. Polycystic ovary syndrome;Franks;N Engl J Med,1995

2. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria;March;Hum Reprod,2010

3. Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS;Puurunen;J Clin Endocrinol Metab,2011

4. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?;Daan;Fertil Steril,2014

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PCOS and common androgen abnormalities in adolescents;NASPAG Essentials of Pediatric & Adolescent Gynecology;2025

2. Correlation of Polycystic Ovarian Syndrome Phenotypes With Pregnancy and Neonatal Outcomes;Obstetrics & Gynecology;2024-08-22

3. Combined Oral Contraceptives for Polycystic Ovary Syndrome: <i>Pro</i> and <i>Contra</i> (Review);Safety and Risk of Pharmacotherapy;2024-06-06

4. Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome;Acta Obstetricia et Gynecologica Scandinavica;2024-05-07

5. Knowledge graph construction based on granulosa cells transcriptome from polycystic ovary syndrome with normoandrogen and hyperandrogen;Journal of Ovarian Research;2024-02-12